BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

3221 related articles for article (PubMed ID: 16091062)

  • 21. Helicobacter pylori infection in dyspeptic cirrhotic patients.
    Zullo A; Rinaldi V; Meddi P; Folino S; Lauria V; Diana F; Winn S; Attili AF
    Hepatogastroenterology; 1999; 46(25):395-400. PubMed ID: 10228829
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Additive deleterious effect of smoking on gastroduodenal pathology and clinical course in Helicobacter pylori-positive dyspeptic patients.
    Moshkowitz M; Brill S; Konikoff FM; Averbuch M; Arber N; Halpern Z
    Isr Med Assoc J; 2000 Dec; 2(12):892-5. PubMed ID: 11344768
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early Helicobacter pylori eradication decreases risk of gastric cancer in patients with peptic ulcer disease.
    Wu CY; Kuo KN; Wu MS; Chen YJ; Wang CB; Lin JT
    Gastroenterology; 2009 Nov; 137(5):1641-8.e1-2. PubMed ID: 19664631
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endoscopic findings and the prevalence of Helicobacter pylori in chronic renal failure patients with dyspepsia.
    Karari EM; Lule GN; McLigeyo SO; Amayo EO
    East Afr Med J; 2000 Aug; 77(8):406-9. PubMed ID: 12862061
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changing rates of Helicobacter pylori testing and treatment in patients with peptic ulcer disease.
    Chiorean MV; Locke GR; Zinsmeister AR; Schleck CD; Melton LJ
    Am J Gastroenterol; 2002 Dec; 97(12):3015-22. PubMed ID: 12492184
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Duodenal Helicobacter pylori associated duodenal ulcer depend on gastric Helicobacter pylori status.
    Vilaichone RK; Mahachai V; Tumwasorn S; Nunthapisud P; Wisedopas N; Kullavanijaya P
    J Med Assoc Thai; 2002 Jun; 85 Suppl 1():S97-102. PubMed ID: 12188459
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Helicobacter pylori eradication may reduce the risk of gastroduodenal lesions in chronic NSAID users.
    Russell RI
    Ital J Gastroenterol Hepatol; 1997 Oct; 29(5):465-9. PubMed ID: 9494858
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Infection with Helicobacter pylori and long-term use of non-steroidal antiinflammatory drugs.
    Vcev A; Ivandić A; Vceva A; Stimac D; Takac B; Mikolasević I; Jovanović S; Dmitrović B; Vuković D; Egić B
    Acta Med Croatica; 1998; 52(1):27-31. PubMed ID: 9599813
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Frequency of Helicobacter pylori infection in dyspeptic patients in Libya.
    Bakka AS; El-Gariani AB; AbouGhrara FM; Salih BA
    Saudi Med J; 2002 Oct; 23(10):1261-5. PubMed ID: 12436134
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence and risk factors for Helicobacter pylori infection among Yemeni dyspeptic patients.
    Gunaid AA; Hassan NA; Murray-Lyon I
    Saudi Med J; 2003 May; 24(5):512-7. PubMed ID: 12847628
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TNF and LTA gene polymorphisms reveal different risk in gastric and duodenal ulcer patients.
    Lanas A; García-González MA; Santolaria S; Crusius JB; Serrano MT; Benito R; Peña AS
    Genes Immun; 2001 Dec; 2(8):415-21. PubMed ID: 11781708
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The prevalence of Helicobacter pylori in peptic ulcer disease.
    Kuipers EJ; Thijs JC; Festen HP
    Aliment Pharmacol Ther; 1995; 9 Suppl 2():59-69. PubMed ID: 8547530
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Decreasing prevalence combined with increasing eradication of Helicobacter pylori infection in the United States has not resulted in fewer hospital admissions for peptic ulcer disease-related complications.
    Manuel D; Cutler A; Goldstein J; Fennerty MB; Brown K
    Aliment Pharmacol Ther; 2007 Jun; 25(12):1423-7. PubMed ID: 17539981
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dyspepsia, peptic ulcer, and H. pylori: a remembrance of things past.
    Vakil N
    Am J Gastroenterol; 2010 Mar; 105(3):572-4. PubMed ID: 20203639
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Helicobacter pylori and peptic ulcer diseases: prevalence and association with antral gastritis in 210 patients.
    Kachintorn U; Luengrojanakul P; Atisook K; Theerabutra C; Tanwandee T; Boonyapisit S; Chinapak O
    J Med Assoc Thai; 1992 Jul; 75(7):386-92. PubMed ID: 1293255
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of non-steroidal anti-inflammatory drug and aspirin use on the prevalence of dyspepsia and uncomplicated peptic ulcer disease.
    Voutilainen M; Mäntynen T; Färkkilä M; Juhola M; Sipponen P
    Scand J Gastroenterol; 2001 Aug; 36(8):817-21. PubMed ID: 11495076
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Seroreactivity to specific antigens of Helicobacter pylori infection is associated with an increased risk of the dyspeptic gastrointestinal diseases.
    Chomvarin C; Ottiwet O; Hahnvajanawong C; Intapan PM; Wongwajana S
    Int J Infect Dis; 2009 Sep; 13(5):647-54. PubMed ID: 19233700
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peptic ulcer frequency differences related to h. Pylori or aines.
    Carli DM; Pires RC; Rohde SL; Kavalco CM; Fagundes RB
    Arq Gastroenterol; 2015; 52(1):46-9. PubMed ID: 26017082
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Helicobacter pylori stool antigen test in patients with bleeding peptic ulcers.
    Lin HJ; Lo WC; Perng CL; Li AF; Tseng GY; Sun IC; Ou YH
    Helicobacter; 2004 Dec; 9(6):663-8. PubMed ID: 15610081
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peptic ulcer disease, irritable bowel syndrome and constipation in two populations in Iran.
    Massarrat S; Saberi-Firoozi M; Soleimani A; Himmelmann GW; Hitzges M; Keshavarz H
    Eur J Gastroenterol Hepatol; 1995 May; 7(5):427-33. PubMed ID: 7614105
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 162.